Roth MKM recommends buying Aspen Aerogels on weakness

Roth MKM keeps a Buy rating and $36 price target on Aspen Aerogels, saying the stock should be bought on Tuesday’s 10% sell-off. The firm is positive on the company’s current positioning, including a clear focus on profitable growth, as its management positions the portfolio for a strong secular opportunity, the analyst tells investors in a research note. 2024 also represents a key inflection point, with Aspen poised to demonstrate positive net income and significant growth for its thermal barrier products, the firm added.